GOLDMAG
Xian Shi
About GOLDMAG
GOLDMAG research, development, production, and sales of related products. They has core invention patents ranging from the synthesis of nanomaterials, the labeling of biomolecules on its surface, and the research on clinical diagnostic methodology. The technology is at that level. and primary prevention of cardiovascular disease .
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $5.0M
- Funding stage: Early Stage Venture
- Last round: Series B (Oct 2017)
- Website: goldmag.com.cn
- Phone: 400-899-9669
Industries & Categories
Biotechnology, Health Care, Medical, Medical Device
Canonical: https://fsome.com/organization/goldmag-101451 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.